Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia–Reperfusion

The cardioprotective effects of nitric oxide (NO) have been described through S-nitrosylation of several important proteins in the mitochondria of the cardiomyocyte. S-nitrosoglutathione reductase (GSNOR) is an enzyme involved in the metabolism of S-nitrosothiols by producing denitrosylation, thus l...

Full description

Bibliographic Details
Main Authors: Oscar Arriagada Castillo, Gustavo Herrera, Carlos Manriquez, Andrea F. Rojas, Daniel R. González
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/4/555
_version_ 1797539011639640064
author Oscar Arriagada Castillo
Gustavo Herrera
Carlos Manriquez
Andrea F. Rojas
Daniel R. González
author_facet Oscar Arriagada Castillo
Gustavo Herrera
Carlos Manriquez
Andrea F. Rojas
Daniel R. González
author_sort Oscar Arriagada Castillo
collection DOAJ
description The cardioprotective effects of nitric oxide (NO) have been described through S-nitrosylation of several important proteins in the mitochondria of the cardiomyocyte. S-nitrosoglutathione reductase (GSNOR) is an enzyme involved in the metabolism of S-nitrosothiols by producing denitrosylation, thus limiting the cardioprotective effect of NO. The effect of GSNOR inhibition on the damage by cardiac ischemia–reperfusion is still unclear. We tested the hypothesis that pharmacological inhibition of GSNOR promotes cardioprotection by increasing the levels of protein S-nitrosylation. In a model of ischemia–reperfusion in isolated rat heart, the effect of a GSNOR inhibitor, 5-chloro-3-(2-[4-ethoxyphenyl) (ethyl) amino]-2-oxoethyl)-1H-indole-2-carboxylic acid (C2), was investigated. Ventricular function and hemodynamics were determined, in addition to tissue damage and S-nitrosylation of mitochondrial proteins. Hearts treated with C2 showed a lower release of myocardial damage marker creatine kinase and a reduction in the infarcted area. It also improved post-ischemia ventricular function compared to controls. These results were associated with increasing protein S-nitrosylation, specifically of the mitochondrial complexes III and V. The pharmacological inhibition of GSNOR showed a concentration-dependent cardioprotective effect, being observed in functional parameters and myocardial damage, which was maximal at 1 µmol/L, associated with increased S-nitrosylation of mitochondrial proteins. These data suggest that GSNOR is an interesting pharmacological target for cardiac reperfusion injury.
first_indexed 2024-03-10T12:39:20Z
format Article
id doaj.art-1c4e1654d1ba4a2dbfab98afb51f1c21
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T12:39:20Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-1c4e1654d1ba4a2dbfab98afb51f1c212023-11-21T14:00:31ZengMDPI AGAntioxidants2076-39212021-04-0110455510.3390/antiox10040555Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia–ReperfusionOscar Arriagada Castillo0Gustavo Herrera1Carlos Manriquez2Andrea F. Rojas3Daniel R. González4Department of Basic Biomedical Sciences, School of Health Sciences, University of Talca, Talca 3460000, ChileDepartment of Basic Biomedical Sciences, School of Health Sciences, University of Talca, Talca 3460000, ChileDepartment of Basic Biomedical Sciences, School of Health Sciences, University of Talca, Talca 3460000, ChileDepartment of Basic Biomedical Sciences, School of Health Sciences, University of Talca, Talca 3460000, ChileDepartment of Basic Biomedical Sciences, School of Health Sciences, University of Talca, Talca 3460000, ChileThe cardioprotective effects of nitric oxide (NO) have been described through S-nitrosylation of several important proteins in the mitochondria of the cardiomyocyte. S-nitrosoglutathione reductase (GSNOR) is an enzyme involved in the metabolism of S-nitrosothiols by producing denitrosylation, thus limiting the cardioprotective effect of NO. The effect of GSNOR inhibition on the damage by cardiac ischemia–reperfusion is still unclear. We tested the hypothesis that pharmacological inhibition of GSNOR promotes cardioprotection by increasing the levels of protein S-nitrosylation. In a model of ischemia–reperfusion in isolated rat heart, the effect of a GSNOR inhibitor, 5-chloro-3-(2-[4-ethoxyphenyl) (ethyl) amino]-2-oxoethyl)-1H-indole-2-carboxylic acid (C2), was investigated. Ventricular function and hemodynamics were determined, in addition to tissue damage and S-nitrosylation of mitochondrial proteins. Hearts treated with C2 showed a lower release of myocardial damage marker creatine kinase and a reduction in the infarcted area. It also improved post-ischemia ventricular function compared to controls. These results were associated with increasing protein S-nitrosylation, specifically of the mitochondrial complexes III and V. The pharmacological inhibition of GSNOR showed a concentration-dependent cardioprotective effect, being observed in functional parameters and myocardial damage, which was maximal at 1 µmol/L, associated with increased S-nitrosylation of mitochondrial proteins. These data suggest that GSNOR is an interesting pharmacological target for cardiac reperfusion injury.https://www.mdpi.com/2076-3921/10/4/555S-nitrosylationheartGSNORmitochondria
spellingShingle Oscar Arriagada Castillo
Gustavo Herrera
Carlos Manriquez
Andrea F. Rojas
Daniel R. González
Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia–Reperfusion
Antioxidants
S-nitrosylation
heart
GSNOR
mitochondria
title Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia–Reperfusion
title_full Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia–Reperfusion
title_fullStr Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia–Reperfusion
title_full_unstemmed Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia–Reperfusion
title_short Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia–Reperfusion
title_sort pharmacological inhibition of s nitrosoglutathione reductase reduces cardiac damage induced by ischemia reperfusion
topic S-nitrosylation
heart
GSNOR
mitochondria
url https://www.mdpi.com/2076-3921/10/4/555
work_keys_str_mv AT oscararriagadacastillo pharmacologicalinhibitionofsnitrosoglutathionereductasereducescardiacdamageinducedbyischemiareperfusion
AT gustavoherrera pharmacologicalinhibitionofsnitrosoglutathionereductasereducescardiacdamageinducedbyischemiareperfusion
AT carlosmanriquez pharmacologicalinhibitionofsnitrosoglutathionereductasereducescardiacdamageinducedbyischemiareperfusion
AT andreafrojas pharmacologicalinhibitionofsnitrosoglutathionereductasereducescardiacdamageinducedbyischemiareperfusion
AT danielrgonzalez pharmacologicalinhibitionofsnitrosoglutathionereductasereducescardiacdamageinducedbyischemiareperfusion